Further analysis of CRC datasets from both The Cancer Genome Atlas (TCGA) and GEO database showed that patients with high expression of TRIB2 suffered significantly worse overall survival (p = 0.004 and p = 0.004, respectively; Fig. 1d). This evidence concerns the gene TRIB2 and colorectal carcinoma.